Guided Therapeutics (GTHP) Operating Expenses (2010 - 2026)
Guided Therapeutics (GTHP) posted Operating Expenses of $1.2 million for Q4 2025, up 124.62% sequentially from $520000.0 in Q3 2025, and up 119.55% YoY from $532000.0 in Q4 2024.
Guided Therapeutics (GTHP) Operating Expenses (2010 - 2026) Analysis & Trends
Guided Therapeutics has reported Operating Expenses for 16 years, with the latest figure at $1.2 million in Q4 2025.
- Quarterly Operating Expenses rose 119.55% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.9 million (up 39.46% YoY) and the FY2025 annual result came in at $2.9 million, up 39.48% from the prior year.
- Operating Expenses rose to $1.2 million in Q4 2025 per GTHP's latest filing, from $520000.0 in the prior quarter.
- Over five years, Operating Expenses peaked at $1.5 million in Q2 2023 and troughed at $363000.0 in Q1 2024.
- A 5-year average of $706850.0 and a median of $591000.0 in 2021 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2021 and 2024: Operating Expenses jumped 240.08% in 2021, then plunged 57.59% in 2024.
- Over 5 years, Operating Expenses stood at $476000.0 in 2021, then jumped by 82.56% to $869000.0 in 2022, then sank by 42.35% to $501000.0 in 2023, then increased by 6.19% to $532000.0 in 2024, then soared by 119.55% to $1.2 million in 2025.
- According to Business Quant data, Operating Expenses over the past three periods registered $1.2 million, $520000.0, and $842000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 10.90 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 2.84 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 3.59 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 2.67 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 846.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 511.70 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 1.44 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | -741.59 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 398.30 Mn |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - | 478,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 478,000.00 |
| Dec 31, 2025 | 1.17 Mn |
| Sep 30, 2025 | 520,000.00 |
| Jun 30, 2025 | 842,000.00 |
| Mar 31, 2025 | 414,000.00 |
| Dec 31, 2024 | 532,000.00 |
| Sep 30, 2024 | 561,000.00 |
| Jun 30, 2024 | 655,000.00 |
| Mar 31, 2024 | 363,000.00 |
| Dec 31, 2023 | 501,000.00 |
| Sep 30, 2023 | 619,000.00 |
| Jun 30, 2023 | 1.52 Mn |
| Mar 31, 2023 | 856,000.00 |
| Dec 31, 2022 | 869,000.00 |
| Sep 30, 2022 | 1.23 Mn |
| Jun 30, 2022 | 721,000.00 |
| Mar 31, 2022 | 447,000.00 |
| Dec 31, 2021 | 476,000.00 |
| Sep 30, 2021 | 464,000.00 |
| Jun 30, 2021 | 563,000.00 |